|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Scleroderma, Circumscribed | |||||
| Scleroderma, Systemic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Scleroderma, Localized | |||||
| 3 | More general conditions related to this trial | ||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||